Lymphoma

Showing NaN - NaN of 134

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Patients With Aggressive Non-Hodgkin's Lymphoma

Completed
  • Lymphoma
  • comparative genomic hybridization
  • +3 more
  • Anniston, Alabama
  • +68 more
Jul 1, 2016

Leukemia, Lymphoma Trial in United States (cyclophosphamide, cytarabine, dexamethasone)

Completed
  • Leukemia
  • Lymphoma
  • La Jolla, California
  • +22 more
Jun 30, 2016

Lymphoma Trial in United States (filgrastim, cyclophosphamide)

Completed
  • Lymphoma
  • Chicago, Illinois
  • +14 more
Jun 30, 2016

Lymphoma Trial in United States (doxorubicin HCl, gemcitabine HCl, vinblastine)

Completed
  • Lymphoma
  • doxorubicin hydrochloride
  • +4 more
  • San Francisco, California
  • +46 more
Jun 30, 2016

Lymphoma Trial in Baltimore, Boston (biological, drug, procedure)

Completed
  • Lymphoma
  • filgrastim
  • +3 more
  • Baltimore, Maryland
  • +1 more
Feb 1, 2016

Kidney Cancer, Leukemia, Lymphoma Trial in Worldwide (Traumeel S, Placebo)

Completed
  • Kidney Cancer
  • +5 more
  • Traumeel S
  • Placebo
  • Birmingham, Alabama
  • +43 more
Jan 5, 2016

GVHD, Lymphoma Trial in Baltimore (biological, drug, procedure, radiation)

Completed
  • Graft Versus Host Disease
  • Lymphoma
  • aldesleukin
  • +6 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jul 16, 2015

Leukemia, Lymphoma Trial in United States (LMB-2 immunotoxin)

Completed
  • Leukemia
  • Lymphoma
  • LMB-2 immunotoxin
  • Atlanta, Georgia
  • +4 more
Apr 29, 2015

Lymphoma, Small Intestine Cancer, Solid Tumor Trial in Baltimore (aldesleukin, bryostatin 1)

Completed
  • Lymphoma
  • +2 more
  • aldesleukin
  • bryostatin 1
  • Baltimore, Maryland
    National Institute on Aging - Baltimore
Apr 28, 2015

Leukemia, Lymphoma Trial in Australia, Canada, United States (arsenic trioxide)

Completed
  • Leukemia
  • Lymphoma
  • arsenic trioxide
  • Little Rock, Arkansas
  • +51 more
Apr 28, 2015

Lymphoma, Multiple Myeloma, Leukemia Trial in Baltimore, Houston, Seattle (Busulfan, Fludarabine, Cytoxan)

Completed
  • Lymphoma
  • +3 more
  • Busulfan, Fludarabine, Cytoxan
  • Baltimore, Maryland
  • +2 more
Jan 29, 2015

Lymphoma Trial in Worldwide (doxorubicin HCl, mercaptopurine, methotrexate)

Completed
  • Lymphoma
  • doxorubicin hydrochloride
  • +5 more
  • Birmingham, Alabama
  • +158 more
Sep 10, 2014

Lymphoma Trial in Worldwide (carmustine, cyclophosphamide, etoposide)

Completed
  • Lymphoma
  • Birmingham, Alabama
  • +234 more
Jul 31, 2014

Lymphoma Trial in Canada, United States (IV Busulfan, Cyclophosphamide and Etoposide (BuCyE Regimen))

Completed
  • Lymphoma
  • IV Busulfan, Cyclophosphamide and Etoposide (BuCyE Regimen)
  • Birmingham, Alabama
  • +41 more
Jul 1, 2014

Cardiac Toxicity, Lymphoma Trial in Canada, Switzerland, United States (biological, drug, radiation)

Completed
  • Cardiac Toxicity
  • Lymphoma
  • bleomycin sulfate
  • +8 more
  • Birmingham, Alabama
  • +62 more
Jul 23, 2014

Lymphoma Trial in United States (bevacizumab, cyclophosphamide, doxorubicin)

Completed
  • Lymphoma
  • bevacizumab
  • +4 more
  • Greenbrae, California
  • +109 more
Apr 8, 2014

Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Baltimore (biological, drug, procedure, radiation)

Completed
  • Leukemia
  • +3 more
  • peripheral blood lymphocyte therapy
  • +4 more
  • Baltimore, Maryland
    Johns Hopkins Oncology Center
May 1, 2014

GVHD, Leukemia, Lymphoma Trial in Baltimore (graft versus host disease prophylaxis/therapy, allogeneic bone marrow

Completed
  • Graft Versus Host Disease
  • +5 more
  • graft versus host disease prophylaxis/therapy
  • +2 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Apr 16, 2014

Lymphoma Follow-up

Completed
  • Lymphoma
    • Baltimore, Maryland
      NIA Clinical Research Unit
    Dec 19, 2013

    Lymphoma Trial in Canada, United States (autologous immunoglobulin idiotype-KLH conjugate vaccine, sargramostim)

    Completed
    • Lymphoma
    • autologous immunoglobulin idiotype-KLH conjugate vaccine
    • sargramostim
    • Stanford, California
    • +10 more
    Dec 18, 2013

    Lymphoma Trial in Canada, United States (autologous immunoglobulin idiotype-KLH conjugate vaccine, keyhole limpet hemocyanin,

    Unknown status
    • Lymphoma
    • autologous immunoglobulin idiotype-KLH conjugate vaccine
    • +5 more
    • Dublin, California
    • +23 more
    Dec 3, 2013

    Lymphoma Trial in Australia, Canada, United States (biological, drug, procedure)

    Completed
    • Lymphoma
    • aldesleukin
    • +10 more
    • Birmingham, Alabama
    • +62 more
    Oct 16, 2013

    Lymphoma Trial in United States (rituximab)

    Terminated
    • Lymphoma
    • rituximab
    • Birmingham, Alabama
    • +8 more
    Jun 14, 2013

    Leukemia, Lymphoma Trial in Worldwide (filgrastim, cyclophosphamide, cytarabine)

    Completed
    • Leukemia
    • Lymphoma
    • filgrastim
    • +9 more
    • Birmingham, Alabama
    • +118 more
    Aug 19, 2013